Natural Management of Fibromyalgia

What Is Actually Happening in Fibromyalgia

Fibromyalgia results from central sensitization — a state in which the brain and spinal cord become hypersensitized to input, turning ordinary sensations into pain and amplifying genuine pain signals far beyond what the tissue injury (if any) would warrant. Functional MRI studies show that patients with fibromyalgia have measurably different pain-processing patterns than healthy controls, with more widespread brain activation in response to the same stimulus.

Several interconnected deficiencies compound the problem:

• Mitochondrial dysfunction: Patients consistently show lower CoQ10 levels, reduced mitochondrial mass, and elevated oxidative stress markers in muscle biopsies and blood. This drives the profound fatigue and muscle aching that cannot be fully explained by pain alone.
• Magnesium deficiency: Magnesium is a natural blocker of the NMDA receptor — the central nervous system receptor most responsible for pain amplification. Low magnesium levels allow NMDA receptors to fire more freely, worsening central sensitization.
• Vitamin D deficiency: Fibromyalgia patients have significantly higher rates of vitamin D deficiency than the general population, and low vitamin D correlates with worse pain scores and functional impairment.
• HPA axis dysregulation: The stress response system is often chronically dysregulated in fibromyalgia, producing abnormal cortisol rhythms that disrupt sleep, pain tolerance, and immune function.
• Sleep fragmentation: Poor sleep — particularly disrupted deep (stage 3/4) sleep — directly worsens pain sensitivity the following day. Sleep disturbance is not just a symptom but an active driver.

Understanding these mechanisms points toward targeted interventions rather than symptom suppression.

Magnesium: Addressing Central Sensitization at the Source

Magnesium malate and magnesium citrate are the preferred forms for fibromyalgia because malate also supports mitochondrial energy production (malic acid is a key Krebs cycle intermediate). Typical doses used in research: 300–450 mg elemental magnesium daily.

A 2013 clinical study found that magnesium citrate supplementation significantly reduced tender point count and the Fibromyalgia Impact Questionnaire (FIQ) score after 8 weeks. Combination with amitriptyline (a low-dose tricyclic sometimes prescribed for fibromyalgia) was more effective than either alone, suggesting synergy between magnesium and drugs that also target central sensitization [1].

See our magnesium page for a detailed look at forms and dosing.

CoQ10: Targeting Mitochondrial Dysfunction

CoQ10 is essential for the mitochondrial electron transport chain. In fibromyalgia, reduced CoQ10 levels correlate with lower energy production and higher oxidative stress. A randomized clinical trial by Cordero et al. found that 300 mg/day of CoQ10 for 40 days significantly reduced chronic pain and fatigue in fibromyalgia patients, with corresponding improvements in mitochondrial function markers [3].

The ubiquinol form (reduced CoQ10) is better absorbed than ubiquinone, particularly in individuals over 40 or those with significant fatigue.

See our CoQ10 page for more on forms and sourcing.

Vitamin D: Correcting a Near-Universal Deficiency

Studies find vitamin D deficiency in 30–75% of fibromyalgia patients, depending on the population — much higher than age-matched controls. Vitamin D receptors are found throughout the central nervous system, and vitamin D modulates neuroinflammation and neurotransmitter synthesis, including serotonin, which is disrupted in fibromyalgia.

A 12-week double-blind RCT found that weekly vitamin D3 supplementation improved functional capacity scores in fibromyalgia patients compared to placebo [4]. A 2022 meta-analysis confirmed improvements in Fibromyalgia Impact Questionnaire scores with supplementation, though effects on pain intensity (VAS scores) were more variable [5].

Testing baseline 25(OH)D levels before supplementing is recommended — a level below 40 ng/mL warrants intervention. Most fibromyalgia patients benefit from 2,000–5,000 IU/day to achieve and maintain optimal levels.

Exercise: Uncomfortable but Essential

The instinct to rest to avoid pain is understandable but counterproductive in fibromyalgia. Graded aerobic exercise is one of the most strongly evidenced interventions — comparable in effect size to pharmacological treatment. Exercise reduces central sensitization, improves mood and sleep, and gradually raises pain thresholds.

Key principles:

• Start very low, go slow: Beginning too intensely triggers post-exertional flares that derail progress. Start at 10–15 minutes of light walking or water aerobics and increase by no more than 10% per week.
• Aim for consistency: 3–4 sessions per week of moderate aerobic activity (walking, swimming, cycling) is the target once tolerance builds.
• Include resistance training: Gentle strength training at least twice weekly reduces fatigue and supports mitochondrial density over time.
• Water-based exercise is particularly well-tolerated in early stages due to reduced gravitational load and warmth, which relaxes muscles.

The Cochrane review on aerobic exercise for fibromyalgia found evidence for improvements in global well-being, physical function, and pain at ACSM-recommended intensities [6].

Sleep Optimization

Non-restorative sleep is both a hallmark symptom and an active perpetuator of fibromyalgia. Without improving sleep quality, other interventions have a lower ceiling. Evidence-supported approaches include:

• Magnesium glycinate (200–400 mg before bed) — enhances deep sleep and reduces nighttime muscle tension
• Melatonin (0.5–3 mg, 30 minutes before bed) — fibromyalgia patients have lower nocturnal melatonin production; supplementation can improve sleep architecture and reduce pain
• Strict sleep hygiene: consistent bedtime and wake time, dark/cool room, no screens 90 minutes before bed
• Treating sleep apnea if present — undiagnosed sleep apnea is common and dramatically worsens fibromyalgia symptoms

See our sleep page and melatonin page for more.

Additional Evidence-Based Approaches

Low-dose naltrexone (LDN): At doses of 1.5–4.5 mg/day (far below the addiction-medicine dose), naltrexone transiently blocks opioid receptors and triggers upregulation of the body's own endorphin production. Small RCTs have shown meaningful pain reduction in fibromyalgia. This requires a prescribing physician but is gaining traction as an off-label option.

Mind-body practices: Mindfulness-based stress reduction (MBSR) has demonstrated moderate reductions in pain and significant improvements in quality of life in multiple RCTs. Yoga and tai chi have also shown benefits — likely through improving sleep, reducing HPA axis dysregulation, and increasing pain tolerance. See our tai chi page.

Anti-inflammatory diet: Reducing processed foods, seed oils, refined sugar, and alcohol while increasing omega-3-rich fish, vegetables, and olive oil addresses the neuroinflammatory component. See our anti-inflammatory foods page.